Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 May;42(5):1293-4.
doi: 10.1128/AAC.42.5.1293.

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial

Affiliations
Clinical Trial

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial

R P Brueckner et al. Antimicrob Agents Chemother. 1998 May.

Abstract

The prophylactic efficacy of WR 238605, a primaquine analog, was studied with a human Plasmodium falciparum challenge model. A single oral dose of 600 mg, administered 1 day prior to challenge, successfully protected three of four subjects. The fourth subject developed mild, oligosymptomatic malaria on day 31, with drug concentrations one-half of those in the protected individuals. WR 238605 appears to be a promising prophylactic drug for P. falciparum malaria.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Structures of WR 238605 and primaquine.

References

    1. Andersen S L, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster B G. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med. 1995;123:771–773. - PubMed
    1. Brueckner, R. P. Unpublished data.
    1. Brueckner, R. P., K. C. Lasseter, E. T. Lin, and B. G. Schuster. First-time-in-human safety and pharmacokinetics of WR 238605, a new antimalarial. Am. J. Trop. Med. Hyg., in press. - PubMed
    1. Brueckner R P, Fleckenstein L. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605) Pharm Res. 1991;8:1505–1510. - PubMed
    1. Fryauff D J, Baird J K, Basri H, Sumawinata I, Purnomo, Richie T L, Ohrt C K, Mouzin E, Curche C J, Richards A L, Subianto B, Sandjaja B, Wignall F S, Hoffman S L. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet. 1995;346:1190–1193. - PubMed

Publication types

LinkOut - more resources